These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Enlarged and phagocytic, but not primed, interleukin-1 alpha-immunoreactive microglia increase with age in normal human brain. Sheng JG; Mrak RE; Griffin WS Acta Neuropathol; 1998 Mar; 95(3):229-34. PubMed ID: 9542587 [TBL] [Abstract][Full Text] [Related]
3. Complement association with neurons and beta-amyloid deposition in the brains of aged individuals with Down Syndrome. Head E; Azizeh BY; Lott IT; Tenner AJ; Cotman CW; Cribbs DH Neurobiol Dis; 2001 Apr; 8(2):252-65. PubMed ID: 11300721 [TBL] [Abstract][Full Text] [Related]
6. [Pro-inflammatory cytokines in Alzheimer's disease]. Stamouli EC; Politis AM Psychiatriki; 2016; 27(4):264-275. PubMed ID: 28114090 [TBL] [Abstract][Full Text] [Related]
7. Influence of microglia and astrocyte activation in the neuroinflammatory pathogenesis of Alzheimer's disease: Rational insights for the therapeutic approaches. Ahmad MH; Fatima M; Mondal AC J Clin Neurosci; 2019 Jan; 59():6-11. PubMed ID: 30385170 [TBL] [Abstract][Full Text] [Related]
8. Adverse effect of a presenilin-1 mutation in microglia results in enhanced nitric oxide and inflammatory cytokine responses to immune challenge in the brain. Lee J; Chan SL; Mattson MP Neuromolecular Med; 2002; 2(1):29-45. PubMed ID: 12230303 [TBL] [Abstract][Full Text] [Related]
9. The neuroinflammatory response in plaques and amyloid angiopathy in Alzheimer's disease: therapeutic implications. Rozemuller AJ; van Gool WA; Eikelenboom P Curr Drug Targets CNS Neurol Disord; 2005 Jun; 4(3):223-33. PubMed ID: 15975026 [TBL] [Abstract][Full Text] [Related]
10. [Inflammatory pathway implication in pathogenesis of Alzheimer's disease]. Liu DG Zhonghua Bing Li Xue Za Zhi; 2003 Jun; 32(3):281-3. PubMed ID: 14518444 [No Abstract] [Full Text] [Related]
11. IFN-γ Production by amyloid β-specific Th1 cells promotes microglial activation and increases plaque burden in a mouse model of Alzheimer's disease. Browne TC; McQuillan K; McManus RM; O'Reilly JA; Mills KH; Lynch MA J Immunol; 2013 Mar; 190(5):2241-51. PubMed ID: 23365075 [TBL] [Abstract][Full Text] [Related]
12. Glial-neuronal interactions in Alzheimer disease: progressive association of IL-1alpha+ microglia and S100beta+ astrocytes with neurofibrillary tangle stages. Sheng JG; Mrak RE; Griffin WS J Neuropathol Exp Neurol; 1997 Mar; 56(3):285-90. PubMed ID: 9056542 [TBL] [Abstract][Full Text] [Related]
13. Neuropathology and the neuroinflammation idea. Mrak RE J Alzheimers Dis; 2009; 18(3):473-81. PubMed ID: 19584454 [TBL] [Abstract][Full Text] [Related]
14. Microglial Priming as Trained Immunity in the Brain. Haley MJ; Brough D; Quintin J; Allan SM Neuroscience; 2019 May; 405():47-54. PubMed ID: 29292078 [TBL] [Abstract][Full Text] [Related]
18. Brain interleukin 1 and S-100 immunoreactivity are elevated in Down syndrome and Alzheimer disease. Griffin WS; Stanley LC; Ling C; White L; MacLeod V; Perrot LJ; White CL; Araoz C Proc Natl Acad Sci U S A; 1989 Oct; 86(19):7611-5. PubMed ID: 2529544 [TBL] [Abstract][Full Text] [Related]
19. Glia and their cytokines in progression of neurodegeneration. Mrak RE; Griffin WS Neurobiol Aging; 2005 Mar; 26(3):349-54. PubMed ID: 15639313 [TBL] [Abstract][Full Text] [Related]
20. Overexpression of human S100B exacerbates cerebral amyloidosis and gliosis in the Tg2576 mouse model of Alzheimer's disease. Mori T; Koyama N; Arendash GW; Horikoshi-Sakuraba Y; Tan J; Town T Glia; 2010 Feb; 58(3):300-14. PubMed ID: 19705461 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]